Ting C C, Hargrove M E, Wang J, Patel A D
Division of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Cell Immunol. 1995 Feb;160(2):286-96. doi: 10.1016/0008-8749(95)80040-p.
This study examined the role of protein tyrosine kinase (PTK) and protein kinase C (PKC) in the signal transduction pathways for lymphocyte activation through IL-2R to generate LAK cells and through TCR-CD3 to generate CD3-AK cells. Two PTK inhibitors [herbimycin A and genistein (PTK-I)] and two PKC inhibitors [calphositin C and staurosporine (PKC-I)] were used in the experiments. It was found that the primary activation pathway through IL-2R was PTK-dependent; that is, generation of both the IL-2-induced proliferative and the cytotoxic responses was completely abrogated by PTK-I and not by PKC-I. Quite different results were obtained with the alpha CD3-induced CD3-AK cell response. First, the alpha CD3-induced proliferation was only partially inhibited by PTK-I or PKC-I alone. Second, generation of CD3-AK cytotoxic response was primarily PKC-dependent; that is, only PKC-I induced significant inhibition. Genistein was found to reduce protein tyrosine phosphorylation in both LAK cells and CD3-AK cells, indicating that CD3-AK cells were also susceptible to PTK-I treatment. Further studies showed that PTK-I and not PKC-I suppressed perforin mRNA expression and N-2-benzyoxycarbonyl-L-lysine thiobeneylester esterase production in LAK cells, and the opposite was true for CD3-AK cells. These results indicate that different pathways were employed in lymphocyte activation through IL-2R and TCR-CD3. The former pathway is primarily PTK-dependent. Activation through TCR-CD3 is a more complex event.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究检测了蛋白酪氨酸激酶(PTK)和蛋白激酶C(PKC)在淋巴细胞激活信号转导途径中的作用,该途径通过白细胞介素-2受体(IL-2R)产生淋巴因子激活的杀伤细胞(LAK细胞)以及通过T细胞受体-CD3(TCR-CD3)产生CD3激活的杀伤细胞(CD3-AK细胞)。实验中使用了两种PTK抑制剂[除莠霉素A和染料木黄酮(PTK-I)]以及两种PKC抑制剂[钙磷蛋白C和星形孢菌素(PKC-I)]。结果发现,通过IL-2R的主要激活途径依赖于PTK;也就是说,PTK-I可完全消除IL-2诱导的增殖反应和细胞毒性反应,而PKC-I则不能。αCD3诱导的CD3-AK细胞反应得到了截然不同的结果。首先,αCD3诱导的增殖仅被单独的PTK-I或PKC-I部分抑制。其次,CD3-AK细胞毒性反应的产生主要依赖于PKC;也就是说,只有PKC-I能诱导显著抑制。研究发现染料木黄酮可降低LAK细胞和CD3-AK细胞中的蛋白酪氨酸磷酸化,这表明CD3-AK细胞也易受PTK-I处理的影响。进一步研究表明PTK-I而非PKC-I可抑制LAK细胞中穿孔素mRNA表达和N-2-苄氧羰基-L-赖氨酸硫代苯甲酯酯酶的产生,而CD3-AK细胞的情况则相反。这些结果表明,通过IL-2R和TCR-CD3激活淋巴细胞采用了不同的途径。前一种途径主要依赖于PTK。通过TCR-CD3的激活是一个更为复杂的过程。(摘要截短于250词)